These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 9825002)

  • 21. Immunohistochemical analysis of CD4+ and CD8+ T-cell subsets in high risk human papillomavirus-associated pre-malignant and malignant lesions of the uterine cervix.
    Monnier-Benoit S; Mauny F; Riethmuller D; Guerrini JS; Căpîlna M; Félix S; Seillès E; Mougin C; Prétet JL
    Gynecol Oncol; 2006 Jul; 102(1):22-31. PubMed ID: 16427684
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Incidence of cervical squamous intraepithelial lesions in HIV-infected women.
    Ellerbrock TV; Chiasson MA; Bush TJ; Sun XW; Sawo D; Brudney K; Wright TC
    JAMA; 2000 Feb; 283(8):1031-7. PubMed ID: 10697063
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Evidence for at least two distinct groups of humoral immune reactions to papillomavirus antigens in women with squamous intraepithelial lesions.
    Strickler HD; Schiffman MH; Eklund C; Glass AG; Scott DR; Sherman ME; Wacholder S; Kurman RJ; Manos MM; Schiller JT; Dillner J
    Cancer Epidemiol Biomarkers Prev; 1997 Mar; 6(3):183-8. PubMed ID: 9138661
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cervical squamous intraepithelial lesions in HIV-infected women: prevalence, incidence and regression. European Study Group on Natural History of HIV Infection in Women.
    Delmas MC; Larsen C; van Benthem B; Hamers FF; Bergeron C; Poveda JD; Anzén B; van den Hoek A; Meier F; Peña JM; Savonius H; Sperandeo D; Suligoi B; Vernazza P; Brunet JB
    AIDS; 2000 Aug; 14(12):1775-84. PubMed ID: 10985315
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Detection of HPV 52, 58 and 87 in cervicovaginal intraepithelial lesions of HIV infected women.
    Haas S; Park TW; Voigt E; Büttner R; Merkelbach-Bruse S
    Int J Mol Med; 2005 Nov; 16(5):815-9. PubMed ID: 16211249
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Soluble interleukin 2 receptor levels and cervical neoplasia: results from a population-based case-control study in Costa Rica.
    Ung A; Kramer TR; Schiffman M; Herrero R; Bratti MC; Burk RD; Swanson CA; Sherman ME; Hutchinson ML; Alfaro M; Morales J; Balmaceda I; Hildesheim A
    Cancer Epidemiol Biomarkers Prev; 1999 Mar; 8(3):249-53. PubMed ID: 10090303
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Viral load of episomal and integrated forms of human papillomavirus type 33 in high-grade squamous intraepithelial lesions of the uterine cervix.
    Khouadri S; Villa LL; Gagnon S; Koushik A; Richardson H; Matlashewski G; Roger M; Ferenczy AS; Franco EL; Coutlée F
    Int J Cancer; 2007 Dec; 121(12):2674-81. PubMed ID: 17708553
    [TBL] [Abstract][Full Text] [Related]  

  • 28. High levels of HPV-16 DNA are associated with high-grade cervical lesions in women at risk or infected with HIV.
    Fontaine J; Hankins C; Mayrand MH; Lefevre J; Money D; Gagnon S; Rachlis A; Pourreaux K; Ferenczy A; Coutlée F;
    AIDS; 2005 May; 19(8):785-94. PubMed ID: 15867492
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. II. Systemic but not local IgA responses correlate with clearance of HPV-16.
    Bontkes HJ; de Gruijl TD; Walboomers JM; Schiller JT; Dillner J; Helmerhorst TJ; Verheijen RH; Scheper RJ; Meijer CJ
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():409-417. PubMed ID: 10073701
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Langerhans cell density in cervical intraepithelial neoplasia associated with human papillomavirus infection in HIV-infected and HIV-noninfected Brazilian women.
    Zimmermmann JB; Gobbi H; Alves MJ; Quirino MG; Melo VH
    Int J Gynecol Cancer; 2012 Oct; 22(8):1291-6. PubMed ID: 22932260
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Immune responses against human papillomavirus (HPV) type 16 virus-like particles in a cohort study of women with cervical intraepithelial neoplasia. I. Differential T-helper and IgG responses in relation to HPV infection and disease outcome.
    de Gruijl TD; Bontkes HJ; Walboomers JM; Coursaget P; Stukart MJ; Dupuy C; Kueter E; Verheijen RH; Helmerhorst TJ; Duggan-Keen MF; Stern PL; Meijer CJ; Scheper RJ
    J Gen Virol; 1999 Feb; 80 ( Pt 2)():399-408. PubMed ID: 10073700
    [TBL] [Abstract][Full Text] [Related]  

  • 32. HPV oligonucleotide microarray-based detection of HPV genotypes in cervical neoplastic lesions.
    Kim CJ; Jeong JK; Park M; Park TS; Park TC; Namkoong SE; Park JS
    Gynecol Oncol; 2003 May; 89(2):210-7. PubMed ID: 12713982
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus infection and time to progression and regression of cervical intraepithelial neoplasia.
    Schlecht NF; Platt RW; Duarte-Franco E; Costa MC; Sobrinho JP; Prado JC; Ferenczy A; Rohan TE; Villa LL; Franco EL
    J Natl Cancer Inst; 2003 Sep; 95(17):1336-43. PubMed ID: 12953088
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cervical abnormalities, human papillomavirus, and human immunodeficiency virus infections in women in Malawi.
    Motti PG; Dallabetta GA; Daniel RW; Canner JK; Chiphangwi JD; Liomba GN; Yang L; Shah KV
    J Infect Dis; 1996 Mar; 173(3):714-7. PubMed ID: 8627037
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Mucosal immunoglobulin-A and -G responses to oncogenic human papilloma virus capsids.
    Sasagawa T; Rose RC; Azar KK; Sakai A; Inoue M
    Int J Cancer; 2003 Apr; 104(3):328-35. PubMed ID: 12569556
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Human papilloma virus infection of uterine cervix and spectrum of cervical pathology in human immunodeficiency virus/AIDS.
    Jain BB; Adhikary T; Sadhukhan PC; Nandi A
    J Cancer Res Ther; 2021; 17(6):1462-1467. PubMed ID: 34916378
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Proliferative T-cell responses to human papillomavirus type 16 E5 are decreased amongst women with high-grade neoplasia.
    Gill DK; Bible JM; Biswas C; Kell B; Best JM; Punchard NA; Cason J
    J Gen Virol; 1998 Aug; 79 ( Pt 8)():1971-6. PubMed ID: 9714245
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Lower genital tract intraepithelial neoplasia in HIV-infected women: guidelines for evaluation and management.
    Spitzer M
    Obstet Gynecol Surv; 1999 Feb; 54(2):131-7. PubMed ID: 9950005
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Cervical neoplasia and repeated positivity of human papillomavirus infection in human immunodeficiency virus-seropositive and -seronegative women.
    Ahdieh L; Muñoz A; Vlahov D; Trimble CL; Timpson LA; Shah K
    Am J Epidemiol; 2000 Jun; 151(12):1148-57. PubMed ID: 10905527
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Risk factors for human papillomavirus and cervical precancerous lesions, and the role of concurrent HIV-1 infection.
    Temmerman M; Tyndall MW; Kidula N; Claeys P; Muchiri L; Quint W
    Int J Gynaecol Obstet; 1999 May; 65(2):171-81. PubMed ID: 10405062
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.